Crestline Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Crestline Management LP
CRD #122711
SEC #801-61607
CIK #0001536054
AUM 22.51 B (2026-03-30)
Employees 195 (58% Investors, 0% Brokers)
Fees
Minimum
Phone817-339-7600
Address201 Main Street
Fort Worth, TX 76102-3135
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
25201510502001200920182027
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
Item 5 - Fees and Compensation

Each fund client sets forth its specific fee structure (including how it charges fees) in a confidential
explanatory memorandum, similar disclosure document or account agreement provided to (in the case of
an account agreement, executed by) prospective investors in the relevant fund client.

Crestline deducts fees from its fund clients either monthly or quarterly, and either in advance (but not more
than three months in advance) or arrears depending on the individual fund client. Crestline deducts the fees
directly from its fund clients. Crestline generally charges one of, or a combination of, the following:

    1. management fees, which are computed on a percentage of assets under management (based on the
       net, total asset value before performance-based compensation, capital commitments or capital
       contributions depending on the client, as disclosed in the relevant governing documents), that,
       depending upon the terms in the governing documents or terms of side letter agreements with
       certain investors: (A) are on a sliding scale; (B) are subject to a minimum floor (expressed in dollars
       or as a percentage of assets under management); and (C) currently range from 0.10% per annum to
       1.75% per annum depending on the fund client (certain fund clients have taken certain actions to
       facilitate the sale or liquidation of certain positions in connection with their winding down; such
       fund clients do not pay a management fee.); and

    2. performance-based allocations, performance-based fees and carried interest compensation, or
       performance-based compensation, which are computed on the percentage of capital appreciation
       the relevant fund client experiences, which range from 8.75% per annum to 20% per annum and
       which, depending upon the terms in the governing documents or terms of side letter agreements
       with certain investors, subject to a “hurdle,” “preferred return” and/or a “high watermark.”
       “Carried interest compensation” is a term that generally refers to performance-based compensation
       to the relevant fund’s general partner or investment manager after repayment of any capital
       contributions and an agreed upon preferred return to the investor when investments are realized.
       Crestline makes direct investments in securities for certain fund clients (as opposed to investments
       in underlying private funds) via special purpose vehicles, for which Crestline may receive
       additional performance-based compensation.

In computing net asset values on which to charge fees/allocations, Crestline applies the guidelines in its
written valuation policy. All assets managed by Crestline are valued according to the valuation
methodologies contained in its valuation policies and in accordance with U.S. Generally Accepted
Accounting Principles (GAAP) – Accounting Standards Codification Topic 820, Fair Value Measurement.

Crestline generally does not negotiate its allocations and fees. Under special circumstances, however,
Crestline enters into agreements with certain investors in its fund clients that provide different terms to
those investors. Crestline has the discretion to waive or reduce its management fee and performance-based
compensation for certain of its related persons or service providers invested in its fund clients.

Crestline Management, L.P.
Form ADV Part 2A – Disclosure Brochure
March 30, 2026

Management agreements to which Crestline is a party are terminable based on the provisions outlined in
each of the fund client’s governing documents and in each relevant management agreement. In the event
of termination of an investment advisory contract or management agreement, Crestline will prorate all
unearned, prepaid fees and refund those unearned fees to the fund clients. Investors in those fund clients
are, however, typically not able to withdraw their capital until the end of a quarter and, therefore, do not
receive pro rata refunds. Certain of Crestline’s illiquid fund clients are also subject to termination fees if
terminated without cause as disclosed in the relevant governing documents.

In addition to the fees paid by the fund clients to Crestline Management, L.P. and to Crestline Associates
Holdings, L.P. (via the entities it owns), to the extent the particular strategy involves investing in underlying
private funds or sub-advisors, the underlying funds and sub-advisors will generally also charge expenses,
such as those set forth in the following paragraph, and an asset-based management fee and performance-
based allocation or fee to the fund clients and that is paid by the fund clients, thereby resulting in two layers
of expenses, fees and allocations. Also, non-Crestline fund client investors that directly invest in a separate
managed account investment will also pay fees to the external managers in addition to the fees paid to
Crestline. However, Crestline fund clients that invest in the separate managed account investment program
will not pay two layers of fees to Crestline.

Fund clients will also pay other expenses in addition to the fees paid to Crestline. For example, depending
upon the terms in the governing documents, fund clients pay portfolio transaction costs, brokerage
commissions, transaction fees, custodial and administration fees, audit and legal fees, registration,
licensing, governmental filing fees, costs of background checks of portfolio managers and management of
target investments, lender expenses, transfer taxes, wire transfer fees and other related fees and taxes. For
information regarding expenses for brokerage expenses, see “Brokerage Practices.” In addition, Crestline
has the discretion to use the services of a third party as part of its diligence process (i.e. background checks
and verifications); such diligence services are in addition to the due diligence conducted by Crestline and
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
Item 7 - Types of Clients

Crestline serves as the investment manager to private domestic fund clients that were formed for the benefit
of U.S. investors, and private offshore fund clients that were formed for the benefit of non-US investors
and U.S. tax-exempt investors. Fund clients include “pooled” investment funds as well as funds for single
investors (including groups of affiliated single investors). Crestline also has a “beta” solutions business
that customizes portfolio overlay and hedging solutions for institutional investors according to the
governing documents of the relevant fund client or investor.

Investors in its fund clients including funds of one (“SMAs”) include:
        • governmental plans, state pension and permanent funds, sovereign wealth funds;
        • private retirement plans, corporate pensions, multi-employer pensions;
        • financial institutions, insurance companies and other institutional clients;
        • foundations, endowments and other charitable organizations; and
        • family offices and high net worth individuals.

Certain investors invest with Crestline via a managed account held at the investor’s designated custodian
which is then managed by Crestline pursuant to an investment management agreement between Crestline
and the investor.

Crestline provides investment advisory services to one or more clients that are insurance companies.
Additionally, Crestline’s affiliate, CL Re SPC, is a reinsurance company, and another Crestline affiliate,
CLIC, acts as the primary cedant to CL Re SPC.

Crestline also provides investment advisory services to an entity that has elected be regulated as a business
development company under the Investment Company Act of 1940, as amended (the “Investment Company
Act”).

In determining whether to launch a fund client, Crestline will look to whether it will have sufficient capital
to meet its fund client’s investment objectives and return goal. Crestline generally requires investors in its
fund clients to be qualified purchasers, as defined in the Investment Company Act and generally requires a
minimum investment of $1,000,000, although Crestline may accept and has accepted lesser amounts.

Crestline Management, L.P.
Form ADV Part 2A – Disclosure Brochure
March 30, 2026
Sector Form 13F Holdings Value ($B)
Denali Therapeutics Inc 0.0
SANA Biotechnology Inc 0.0
8X8 Inc /DE/ 0.0
 
 
 
 
 
 
 
 
Holdings by Sector ($B)
4.03.22.41.60.80.02015201920232027
Type Form D Funds Date Sold AUM
HF CL AK Broadstreet LP 2026-02-27 101.4 M
HF CL Meadow LLC 2026-02-27 24.5 M
HF Crestline European Capital Solutions Fund II SCSP [2025-03-31] 157.7 M 458.6 M
Filed 2025-10-24 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Crestline Portfolio Financing Fund III SCSP [2025-03-31] 325.2 M 424.7 M
Filed 2025-11-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $5,000,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF CL FLS 1 LP 2025-02-28 3.2 M
HF CL Green Park LP [2024-11-27] 81.4 M
Filed 2024-07-15 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Crestline Lending Solutions LLC [2024-11-27] 219.1 M
Filed 2024-08-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
HF Crestline Structured Note Issuer I LLC 2024-08-29 291.2 M
Other Dynamite LP 2024-08-29 10.1 M
HF CL Nevermore LP [2024-02-29] 37.7 M
Filed 2023-11-08 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 1 0.5
(f) Pooled investment vehicles 100 12.6
(g) Pension and profit sharing plans 9 4.8
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.8
(j) Other investment advisers 0 0.1
(k) Insurance companies 5 2.6
(l) Sovereign wealth funds and foreign official institutions 16 0.9
(m) Corporations or other businesses not listed above 0 0.1
(n) Other 0 0.0
Total 135 22.5
By Discretionary
Discretionary 135 22.5
Non-Discretionary 0 0.0
Total 135 22.5
By Non-United States Persons
Non-United States Persons 16.2
United States Persons 6.3
Total 135 22.5
Form D Directors Role # Filings # Firms 2011 - 2026
Karla Bodden Director 186 22
J Hunter Director 61 13
Dennis Hunter Director 132 12
Darren Gorman Director 124 8
Jane Fleming Director 26 8
Robert Watson Executive Officer 54 5
Maurice Murphy Director 8 5
Therese Collins Director 7 5
Crestline Management LP Executive Officer, Promoter 87 4
Kevin Ryan Director 63 4
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001536054]
13F-NT [0001536054]
3 [0001536054]
4 [0001536054]
Firm Profile (Form ADV)
Discretionary AUM$6.4B
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI5ZQYRF3Z9W001NF39K35
Form 3/4/5 Subject 2011 - 2026
Crestline Assurance Holdings LLC
Crestline Management LP
Bratton Douglas K
Crestline Investors Inc
Midwest Holding Inc
Crestline SI GP LP
AKDL LP
Denali Therapeutics Inc
Neuro Line Partners LP
Bratton Capital Inc
Bratton Capital Management LP
CL Alaska LP
Juno Therapeutics Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Midwest Holding Inc MDWT
Voting Common Stock
2022-06-14 Grant 2,674 $0.00
Midwest Holding Inc MDWT
Voting Common Stock
2021-11-11 Grant 727 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2021-02-12 Sell 2,216,798 $65.00 144,091,870
Denali Therapeutics Inc DNLI
Common Stock
2020-08-12 Sell 1,443,247 $31.65 45,678,768
Midwest Holding Inc MDWT
Stock Option (right to buy) · derivative
2020-07-31 Grant 50,000 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2020-06-05 Sell 1,922,855 $25.75 49,513,516
Denali Therapeutics Inc DNLI
Common Stock
2020-02-26 Sell 3,894,764 $20.25 78,868,971
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 14,499,999
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 2,500,000
Denali Therapeutics Inc DNLI
Series A-1 Convertible Preferred Stock · derivative
2017-12-12 Conversion 14,499,999 $0.00
Denali Therapeutics Inc DNLI
Series A-1 Convertible Preferred Stock · derivative
2017-12-12 Conversion 743,599 $0.00
Denali Therapeutics Inc DNLI
Series B-1 Convertible Preferred Stock · derivative
2017-12-12 Conversion 1,875,000 $0.00
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
2017-12-12 Conversion 2,500,000 $0.00
Denali Therapeutics Inc DNLI
Series B-1 Convertible Preferred Stock · derivative
2017-12-12 Conversion 240,000 $0.00
Denali Therapeutics Inc DNLI
Series A-2 Convertible Preferred Stock · derivative
2017-12-12 Conversion 128,200 $0.00
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 240,000
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Buy 275,000 $18.00 4,950,000
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 128,200
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 743,599
Denali Therapeutics Inc DNLI
Common Stock
2017-12-12 Conversion 1,875,000
showing 20 of 33 most recent transactions
Comparable Firms State AUM
Strategic Value Partners LLC
CT 25.61 B
KSL Advisors LLC
CO 25.61 B
Providence Equity Partners LLC
RI 24.12 B
Templeton Asset Management Ltd
24.05 B
New Holland Capital LLC
NY 23.32 B
Benefit Street Partners Limited
22.61 B
Dawson Partners Inc
22.14 B
Lone Pine Capital LLC
CT 21.62 B
OrbiMed Advisors LLC
NY 20.61 B
Hildene Capital Management LLC
CT 20.18 B
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com